- Our Company
- News & Events
- Contact Us
Congratulations to these authors! ESMO Asia 2023 saw four poster presentations and one mini oral session where the data from Guardant Health’s tests was utilized and presented by leading medical oncologists such as Dr. Po-Sheng Yang from Taiwan, Dr. Nitesh Rohatgi from India, Dr. Byoung Chul Cho from South Korea and Dr. Shaheenah Dawood from U.A.E. It is becoming evident that comprehensive genomic profiling is quickly gaining importance in guiding treatment decisions for patients with cancer across all stages of the disease and that comprehensive liquid biopsies offered by Guardant Health are becoming game changers in precision oncology.
Visit us at https://lnkd.in/gHNdYtQN to find out more about Guardant Health’s comprehensive genomic profiling tests which can help guide treatment decisions for patients with cancer.
#guardanthealthamea #guardanthealth #ESMOAsia #ESMO #comprehensivegenomicprofiling #precisiononcology #liquidbiopsy #liquidissolid #gamechanger #clinicalresearch #abstracts #medicaloncologists #oncologists